European guidelines for quality assurance in breast cancer screening and diagnosis. -summary document

N Perry, M Broeders, C de Wolf… - Oncology in Clinical …, 2008 - journals.viamedica.pl
Breast cancer is a major cause of suffering and death and is of significant concern to many
women. Early detection of breast cancer by systematic mammography screening can find …

Preoperative chemotherapy for women with operable breast cancer

JH van der Hage, CJH van de Velde… - Cochrane database …, 2007 - cochranelibrary.com
Background Currently, preoperative chemotherapy is the standard of care in locally
advanced breast cancer to achieve local tumour downsizing in order to make surgery …

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant …

V Graziano, A Grassadonia, L Iezzi, P Vici, L Pizzuti… - The Breast, 2019 - Elsevier
The immune system seems to play a fundamental role in breast cancer responsiveness to
chemotherapy. We investigated two peripheral indicators of immunity/inflammation, ie …

Early breast cancer

JR Benson, I Jatoi, M Keisch, FJ Esteva, A Makris… - The Lancet, 2009 - thelancet.com
Adoption of urbanised lifestyles together with changes in reproductive behaviour might
partly underlie the continued rise in worldwide incidence of breast cancer. Widespread …

[PDF][PDF] Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III …

HJ Burstein, LN Harris, R Gelman… - Journal of Clinical …, 2003 - researchgate.net
Conclusion: Preoperative trastuzumab and paclitaxel is active against HER2 overexpressing
early-stage breast cancer and may be feasible as part of a sequential treatment program …

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer

V Stearns, CA Ewing, R Slack, MF Penannen… - Annals of surgical …, 2002 - Springer
Background After neoadjuvant chemotherapy, women with locally advanced breast cancer
(LABC) undergo a modified radical mastectomy or lumpectomy with axillary lymph node …

Studies of apoptosis in breast cancer

M Parton, M Dowsett, I Smith - Bmj, 2001 - bmj.com
Studies of apoptosis in breast cancer | The BMJ Skip to main content Intended for healthcare
professionals Access provided by Google Indexer Subscribe My Account My email alerts BMA …

Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis

Y Wang, C Zhang, J Liu, G Huang - Breast cancer research and treatment, 2012 - Springer
Clinical evidence regarding the value of 18 F-FDG PET for therapy responses assessment in
breast cancer is increasing. The objective of this study is to evaluate the accuracy of 18 F …

Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer

JD Keune, DB Jeffe, M Schootman, A Hoffman… - The American Journal of …, 2010 - Elsevier
BACKGROUND: Neoadjuvant chemotherapy reduces tumor size before surgery in women
with breast cancer. The aim of this study was to assess the ability of mammography and …

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer

MAA Koike Folgueira, DM Carraro, H Brentani… - Clinical Cancer …, 2005 - AACR
Purpose: This study was designed to identify genes that could predict response to
doxorubicin-based primary chemotherapy in breast cancer patients. Experimental Design …